SOLID PREPARATIONS CONTAINING PELARGONIUM SIDOIDES EXTRACTS AND SILICIC ACID COMPOUND, AND PREPARING METHOD THEREOF
원문보기
IPC분류정보
국가/구분
United States(US) Patent
공개
국제특허분류(IPC7판)
A61K-036/185
A61K-009/20
출원번호
US-0889619
(2014-12-19)
공개번호
US-0287651
(2016-10-06)
우선권정보
KR-10-2013-0159980 (2013-12-20)
국제출원번호
PCT/KR2014/012592
(2014-12-19)
발명자
/ 주소
Choi, Youn Woong
Min, Byung Gu
Cho, Sang Min
Ki, Do Hyoung
Ahn, Ji Hyun
Lee, Byung Hoon
Jun, Hyung Joon
Jung, Won Tae
Nam, Kyu Yeol
Lee, Dong Gyu
Chung, Jin Seong
출원인 / 주소
Korea United Pharm. Inc.
인용정보
피인용 횟수 :
0인용 특허 :
0
초록▼
The present invention relates to a solid preparation including a Pelargonium sidoides extract and a silicic acid compound, which is allowed to be formulated in a solid form by direct adsorption of the Pelargonium sidoides extract onto a silicic acid compound, and a preparation method thereof. Since
The present invention relates to a solid preparation including a Pelargonium sidoides extract and a silicic acid compound, which is allowed to be formulated in a solid form by direct adsorption of the Pelargonium sidoides extract onto a silicic acid compound, and a preparation method thereof. Since the solid preparation including the Pelargonium sidoides extract and the silicic acid compound of the present invention has higher stability than a liquid preparation such as syrup, and has no additives such as sugars, there is no concern about microbial contamination or spoilage of the preparation. In addition, it is possible to pack the solid preparation individually. Since the solid preparation is smaller in volume than the liquid preparation, it is highly portable, and there is also a convenience that no additional tools are needed to take the drug. Further, the active ingredient can be taken at the equal amount every time.
대표청구항▼
1. A solid preparation comprising a Pelargonium sidoides extract and a silicic acid compound. 2. The solid preparation according to claim 1, wherein the silicic acid compound is one or more selected from the group consisting of calcium silicate, colloidal silicon dioxide and aluminium magnesium sili
1. A solid preparation comprising a Pelargonium sidoides extract and a silicic acid compound. 2. The solid preparation according to claim 1, wherein the silicic acid compound is one or more selected from the group consisting of calcium silicate, colloidal silicon dioxide and aluminium magnesium silicate. 3. The solid preparation according to claim 1, wherein the silicic acid compound adsorbs the Pelargonium sidoides extract. 4. The solid preparation according to claim 1, wherein the extract is obtained by performing extraction using one selected from the group consisting of water, ethanol, methanol, propanol and butanol, or a mixture of two or more thereof as a solvent. 5. The solid preparation according to claim 1, wherein the Pelargonium sidoides extract and the silicic acid compound are mixed at a weight ratio of 1:0.5 to 1:6. 6. The solid preparation according to claim 1, wherein the solid preparation is one or more selected from the group consisting of a tablet, a pill, a capsule, a powder and a granule. 7. The solid preparation according to claim 1, wherein the solid preparation is used for the treatment of respiratory diseases. 8. The solid preparation according to claim 7, wherein the respiratory disease is one or more selected from the group consisting of cold, cough, asthma, tonsillitis, sore throat, tuberculosis, and chronic bronchitis. 9. A method for preparing the solid preparation according to claim 1 by mixing a Pelargonium sidoides extract with a silicic acid compound. 10. The method according to claim 9, wherein the Pelargonium sidoides extract and the silicic acid compound are mixed at a weight ratio of 1:0.5 to 1:6. 11. A method for treating a respiratory disease, comprising administering the solid preparation of claim 1 comprising a Pelargonium sidoides extract and a silicic acid compound to a subject in need thereof. 12. The method of claim 11, wherein the respiratory disease is one or more selected from the group consisting of cold, cough, asthma, tonsillitis, sore throat, tuberculosis, and chronic bronchitis. 13. The method of claim 11, wherein the silicic acid compound is one or more selected from the group consisting of calcium silicate, colloidal silicon dioxide and aluminium magnesium silicate. 14. The method of claim 11, wherein the silicic acid compound adsorbs the Pelargonium sidoides extract. 15. The method of claim 11, wherein the extract is obtained by performing extraction using one selected from the group consisting of water, ethanol, methanol, propanol and butanol, or a mixture of two or more thereof as a solvent. 16. The method of claim 11, wherein the Pelargonium sidoides extract and the silicic acid compound are mixed at a weight ratio of 1:0.5 to 1:6. 17. The method of claim 11, wherein the solid preparation is one or more selected from the group consisting of a tablet, a pill, a capsule, a powder and a granule. 18. The method of claim 11, wherein the solid preparation is a tablet comprising a Pelargonium sidoides extract and calcium silicate, at a weight ratio of 1:1.5 to 1:5. 19. A tablet comprising a Pelargonium sidoides extract and calcium silicate, at a weight ratio of 1:1.5 to 1:5. 20. A method for preparing a tablet by mixing a Pelargonium sidoides extract with calcium silicate, at a weight ratio of 1:1.5 to 1:5.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.